Alterity Therapeutics (ATHE) Accounts Payables (2017 - 2018)
Alterity Therapeutics (ATHE) has 2 years of Accounts Payables data on record, last reported at $1.0 million in Q2 2018.
- For Q2 2018, Accounts Payables rose 50.63% year-over-year to $1.0 million; the TTM value through Jun 2018 reached $1.0 million, up 50.63%, while the annual FY2018 figure was $1.0 million, 50.06% up from the prior year.
- Accounts Payables reached $1.0 million in Q2 2018 per ATHE's latest filing, up from $670405.6 in the prior quarter.
- Across five years, Accounts Payables topped out at $1.0 million in Q2 2018 and bottomed at $670405.6 in Q2 2017.